Barriers
In our study, most patients state complaints or gastroprotection and fewer self-reported diagnosis as reason for their PPI use at T1. This reflects the importance of symptomatic control. That makes PPI “notoriously hard to reduce” because they offer symptomatic relief in comparison to other PIMs like statinsSome GPs expect the stereotype of a patient demanding PPI prescriptions or of using PPI to support an unhealthy lifestyleGastroprotection with PPI during NSAID therapy may become relevant in patients older than 60 years and with risk factors